BIOMAT Database Logo BIOMAT Database Logo

14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle. 2002

Teemu O Takala, and Pirjo Nuutila, and Kari Pulkki, and Vesa Oikonen, and Tove Grönroos, and Timo Savunen, and Tommi Vähäsilta, and Matti Luotolahti, and Markku Kallajoki, and Jörgen Bergman, and Sarita Forsback, and Juhani Knuuti
Turku PET Centre, Turku University Central Hospital, PO Box 52, 20521 Turku, Finland.

14( R, S)-[(18)F]Fluoro-6-thia-heptadecanoic acid ([(18)F]FTHA) is a long-chain fatty acid substrate for fatty acid metabolism. [(18)F]FTHA has been used to study fatty acid metabolism in human heart and skeletal muscle. It has been suggested that the rate of radioactivity accumulation in the myocardium reflects the beta-oxidation rate of free fatty acids (FFAs). However, the net accumulation of FFAs in tissue always represents the sum of FFA oxidation and incorporation into triglycerides. The fraction of [(18)F]FTHA entering directly into mitochondria for oxidation has not been previously measured. Eight anaesthetized pigs were studied with [(18)F]FTHA and positron emission tomography (PET). Immediately after each PET experiment, tissue samples from myocardium and skeletal muscle were taken for the isolation of mitochondria and measurements of radioactivity accumulation, and for intracellular [(18)F]FTHA metabolite analysis. Fractional [(18)F]FTHA uptake rates were calculated both by graphical analysis of PET data and by measuring (18)F in the tissue samples. Fractional [(18)F]FTHA uptake rates based on the analysis of tissue samples were 0.56+/-0.17 ml g(-1) min(-1) and 0.037+/-0.007 ml g(-1) min(-1) for myocardium and skeletal muscle (mean +/- SD), respectively. The myocardial results obtained from the PET data (0.50+/-0.11 ml g(-1) min(-1)) were similar to the values obtained from the tissue samples ( r=0.94, P=0.002). We also found that 89%+/-23% (mean+/-SD, n=7) of the (18)F entered mitochondria in myocardium, as compared with only 36%+/-15% (mean+/-SD, n=7) in skeletal muscle. Intracellular [(18)F]FTHA metabolite analysis showed that a major part of [(18)F]FTHA is metabolized in the mitochondria in the heart. Our data suggest that ~89% of [(18)F]FTHA taken up by the heart enters mitochondria. This supports the hypothesis that [(18)F]FTHA traces FFA beta-oxidation in the heart. In contrast to this, only ~36% of [(18)F]FTHA accumulated in skeletal muscle appears to directly enter mitochondria; the majority is taken up by the other cell fractions, suggesting that in skeletal muscle [(18)F]FTHA traces FFA uptake but not specifically FFA beta-oxidation.

UI MeSH Term Description Entries
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008929 Mitochondria, Heart The mitochondria of the myocardium. Heart Mitochondria,Myocardial Mitochondria,Mitochondrion, Heart,Heart Mitochondrion,Mitochondria, Myocardial
D008931 Mitochondria, Muscle Mitochondria of skeletal and smooth muscle. It does not include myocardial mitochondria for which MITOCHONDRIA, HEART is available. Sarcosomes,Mitochondrion, Muscle,Muscle Mitochondria,Muscle Mitochondrion,Sarcosome
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D006352 Heart Ventricles The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation. Cardiac Ventricle,Cardiac Ventricles,Heart Ventricle,Left Ventricle,Right Ventricle,Left Ventricles,Right Ventricles,Ventricle, Cardiac,Ventricle, Heart,Ventricle, Left,Ventricle, Right,Ventricles, Cardiac,Ventricles, Heart,Ventricles, Left,Ventricles, Right
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog

Related Publications

Teemu O Takala, and Pirjo Nuutila, and Kari Pulkki, and Vesa Oikonen, and Tove Grönroos, and Timo Savunen, and Tommi Vähäsilta, and Matti Luotolahti, and Markku Kallajoki, and Jörgen Bergman, and Sarita Forsback, and Juhani Knuuti
Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid.
August 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Teemu O Takala, and Pirjo Nuutila, and Kari Pulkki, and Vesa Oikonen, and Tove Grönroos, and Timo Savunen, and Tommi Vähäsilta, and Matti Luotolahti, and Markku Kallajoki, and Jörgen Bergman, and Sarita Forsback, and Juhani Knuuti
A Fully Automated Synthesis of 14-(R,S)-[18F]fluoro-6-thia-heptadecanoic Acid ([18F]FTHA) on the Elixys Radiosynthesizer.
February 2024, Pharmaceuticals (Basel, Switzerland),
Teemu O Takala, and Pirjo Nuutila, and Kari Pulkki, and Vesa Oikonen, and Tove Grönroos, and Timo Savunen, and Tommi Vähäsilta, and Matti Luotolahti, and Markku Kallajoki, and Jörgen Bergman, and Sarita Forsback, and Juhani Knuuti
Production and biological evaluation of [18F]-6-thia-14-fluoro-heptadecanoic acid.
January 2006, Nuclear medicine review. Central & Eastern Europe,
Teemu O Takala, and Pirjo Nuutila, and Kari Pulkki, and Vesa Oikonen, and Tove Grönroos, and Timo Savunen, and Tommi Vähäsilta, and Matti Luotolahti, and Markku Kallajoki, and Jörgen Bergman, and Sarita Forsback, and Juhani Knuuti
The effect of insulin on the intracellular distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid in rats.
January 2006, Molecular imaging and biology,
Teemu O Takala, and Pirjo Nuutila, and Kari Pulkki, and Vesa Oikonen, and Tove Grönroos, and Timo Savunen, and Tommi Vähäsilta, and Matti Luotolahti, and Markku Kallajoki, and Jörgen Bergman, and Sarita Forsback, and Juhani Knuuti
14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid (FTHA): evaluation in mouse of a new probe of myocardial utilization of long chain fatty acids.
October 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Teemu O Takala, and Pirjo Nuutila, and Kari Pulkki, and Vesa Oikonen, and Tove Grönroos, and Timo Savunen, and Tommi Vähäsilta, and Matti Luotolahti, and Markku Kallajoki, and Jörgen Bergman, and Sarita Forsback, and Juhani Knuuti
Myocardial uptake of the fatty acid analog 14-fluorine-18-fluoro-6-thia-heptadecanoic acid in comparison to beta-oxidation rates by tritiated palmitate.
October 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Teemu O Takala, and Pirjo Nuutila, and Kari Pulkki, and Vesa Oikonen, and Tove Grönroos, and Timo Savunen, and Tommi Vähäsilta, and Matti Luotolahti, and Markku Kallajoki, and Jörgen Bergman, and Sarita Forsback, and Juhani Knuuti
An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
January 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Teemu O Takala, and Pirjo Nuutila, and Kari Pulkki, and Vesa Oikonen, and Tove Grönroos, and Timo Savunen, and Tommi Vähäsilta, and Matti Luotolahti, and Markku Kallajoki, and Jörgen Bergman, and Sarita Forsback, and Juhani Knuuti
Kinetics of 14(R,S)-fluorine-18-fluoro-6-thia-heptadecanoic acid in normal human hearts at rest, during exercise and after dipyridamole injection.
January 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Teemu O Takala, and Pirjo Nuutila, and Kari Pulkki, and Vesa Oikonen, and Tove Grönroos, and Timo Savunen, and Tommi Vähäsilta, and Matti Luotolahti, and Markku Kallajoki, and Jörgen Bergman, and Sarita Forsback, and Juhani Knuuti
Preliminary evaluation of 15-[18F]fluoro-3-oxa-pentadecanoate as a PET tracer of hepatic fatty acid oxidation.
October 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Teemu O Takala, and Pirjo Nuutila, and Kari Pulkki, and Vesa Oikonen, and Tove Grönroos, and Timo Savunen, and Tommi Vähäsilta, and Matti Luotolahti, and Markku Kallajoki, and Jörgen Bergman, and Sarita Forsback, and Juhani Knuuti
A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease.
August 2014, Synapse (New York, N.Y.),
Copied contents to your clipboard!